logo
AAT Bioquest

Somatostatin receptor Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
CamptothecinIC502.21 [1]
SomatostatinIC500.83 [1]
(4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2S,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamideIC501.1 [1]
NaluzotanKi2000.0 [1]
N-[1-(6,7-Dihydro-5H-cyclopenta[f][1,3]benzodioxol-7-yl)piperidin-4-yl]-6-fluoro-4-oxochromene-2-carboxamideIC5010000.0 [1]
5-[[6-[2-(1H-Indol-2-yl)ethoxy]-3,4,5-tris(phenylmethoxy)oxan-2-yl]methylamino]pentan-1-olIC5014000.0 [1]
6-[[6-[2-(1H-Indol-2-yl)ethoxy]-3,4,5-tris(phenylmethoxy)oxan-2-yl]methylamino]hexan-1-olIC505100.0 [1]
5-[[6-[2-(1H-Indol-2-yl)ethoxy]-3,5-bis(phenylmethoxy)oxan-2-yl]methoxy]pentan-1-amineIC508400.0 [1]
6-[[6-[2-(1H-Indol-2-yl)ethoxy]-3,5-bis(phenylmethoxy)oxan-2-yl]methoxy]hexan-1-amineIC506600.0 [1]
5-[[6-[2-(1H-Indol-2-yl)ethoxy]-3,5-bis(phenylmethoxy)oxan-2-yl]methylamino]pentan-1-olIC5010000.0 [1]
6-[[6-[2-(1H-Indol-2-yl)ethoxy]-3,5-bis(phenylmethoxy)oxan-2-yl]methylamino]hexan-1-olIC5034000.0 [1]
5-[[6-[2-(1H-Indol-2-yl)ethoxy]-3,4-bis(phenylmethoxy)oxan-2-yl]methoxy]pentan-1-amineIC5035000.0 [1]
5-[[6-[2-(1H-Indol-2-yl)ethoxy]-4,5-bis(phenylmethoxy)oxan-2-yl]methoxy]pentan-1-amineIC5047000.0 [1]
(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-Amino-3-[[2-[2-[(2R,5S,8S,11S,14S,17S)-11-(4-aminobutyl)-17-benzyl-14-[(1R)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-8-(1H-indol-3-ylmethyl)-1-methyl-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]propanoyl]amino]-3-(4-aminophenyl)propanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoic acidIC500.2 [1]
(2S,3R)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-Amino-3-[[2-[2-[(2R,5S,8S,11S,14S,17S)-11-(4-aminobutyl)-17-benzyl-14-[(1R)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-8-(1H-indol-3-ylmethyl)-1-methyl-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]propanoyl]amino]-3-(4-aminophenyl)propanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxybutanoic acidIC500.64 [1]
(2S)-2-[[(2S)-2-Amino-3-[[2-[2-[(2R,5S,8S,11S,14S,17S)-11-(4-aminobutyl)-17-benzyl-14-[(1R)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-8-(1H-indol-3-ylmethyl)-1-methyl-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]propanoyl]amino]-3-(4-aminophenyl)-N-[(2R)-1-[[(2R,3R)-1,3-dihydroxybutan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]propanamideIC500.5 [1]
(2S)-2-Amino-3-[[2-[2-[(2R,5S,8S,11S,14S,17S)-11-(4-aminobutyl)-17-benzyl-14-[(1R)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-8-(1H-indol-3-ylmethyl)-1-methyl-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]-N-[(2S)-1-[[(2R)-1-[[(2R,3R)-1,3-dihydroxybutan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]propanamideIC501.6 [1]
(2S)-6-Amino-2-[[(2S)-2-amino-3-[[2-[2-[(2R,5S,8S,11S,14S,17S)-11-(4-aminobutyl)-17-benzyl-14-[(1R)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-8-(1H-indol-3-ylmethyl)-1-methyl-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]propanoyl]amino]-N-[(2R)-1-[[(2R,3R)-1,3-dihydroxybutan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]hexanamideIC500.35 [1]
(2S,3R)-2-[[2-[2-[(2R,5S,8S,11S,14S,17S)-11-(4-Aminobutyl)-17-benzyl-14-[(1R)-1-hydroxyethyl]-5-[(4-hydroxyphenyl)methyl]-8-(1H-indol-3-ylmethyl)-1-methyl-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]-N-[2-[[2-[[(2R)-1-amino-1-oxo-3-sulfanylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]-3-hydroxybutanamideIC501.6 [1]
(1R,4S,7R,13S,16S,19R)-19-(4-Aminobutyl)-4,13-dibenzyl-16-[(1R)-1-hydroxyethyl]-2,5,14,17,22-pentazapentacyclo[18.10.1.07,11.021,29.023,28]hentriaconta-21(29),23,25,27-tetraene-3,6,12,15,18,31-hexoneIC5015000.0 [1]
5-[[(2S,3R,4S,5S,6R)-6-[2-(1H-Indol-2-yl)ethoxy]-3,4,5-tris(phenylmethoxy)oxan-2-yl]methoxy]pentan-1-amineIC5015000.0 [1]
6-[[(2S,3R,4S,5S,6R)-6-[2-(1H-Indol-2-yl)ethoxy]-3,4,5-tris(phenylmethoxy)oxan-2-yl]methoxy]hexan-1-amineIC5011000.0 [1]
[2-Methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] N-(2-aminoethyl)-N-[2-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(4S,7S,10S,13R,16S,19S)-4-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]-10-(3-aminopropyl)-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]carbamateIC502.79 [1]
[(19S)-19-Ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl] N-[2-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(4S,7S,10S,13R,16S,19S)-4-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]-10-(3-aminopropyl)-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]-N-(2-hydroxyethyl)carbamateIC501000.0 [1]
[(19S)-19-Ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl] N-[2-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(4S,7S,10S,13R,16S,19S)-4-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]-10-(3-aminopropyl)-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]-N-[2-(methylamino)ethyl]carbamateIC5054.2 [1]
[(19S)-19-Ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl] N-[2-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(4S,7S,10S,13R,16S,19S)-4-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]-10-(3-aminopropyl)-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]-N-[2-(dimethylamino)ethyl]carbamateIC50571.0 [1]
[(19S)-19-Ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl] N-[2-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(4S,7S,10S,13R,16S,19S)-4-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]-10-(3-aminopropyl)-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]-N-(3-aminopropyl)carbamateIC501000.0 [1]
SandostatinmIC500.46 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Somatostatin receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc.9 May2024https://www.aatbio.com/data-sets/somatostatin-receptor-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024May 9). Quest Database™ Somatostatin receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/somatostatin-receptor-inhibitors-ic50-ki.
BibTeXEndNoteRefMan